BARCLAYS PLC

Position in LENZ — LENZ Therapeutics, Inc.

CIK 312069 LONDON, X0

Position in LENZ

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$284,595

-$1,100,595 QoQ

Shares Held

50,105

-66.9% QoQ

Ownership

0.159%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#54

of 143 holders

Holding Since

Mar 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,204,586 across 455 Biotechnology names. LENZ ranks #203 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	733,274	$364,239,192
2	REGN	Regeneron Pharmaceuticals, Inc.	256,192	$159,745,957
3	IONS	Ionis Pharmaceuticals Inc	1,603,136	$127,112,653
4	ARGX	Argenx SE	134,427	$124,717,337
5	MRNA	Moderna, Inc.	1,035,126	$72,489,872
6	BBIO	BridgeBio Pharma, Inc.	714,423	$53,210,224
7	TGTX	Tg Therapeutics, Inc.	957,848	$52,624,168
8	DNTH	Dianthus Therapeutics, Inc. /DE/	431,753	$42,087,281

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$284,595	50,105	-66.9%	Shares	Defined	2026-08-14
2026-03-31	$1,385,190	151,387	+109.0%	Shares	Defined	2026-05-15
2025-12-31	$1,158,912	72,432	+51.4%	Shares	Sole	2026-02-13
2025-09-30	$2,227,734	47,826	+4.4%	Shares	Sole	2026-03-31
2025-06-30	$1,342,689	45,810	+87.7%	Shares	Sole	2026-02-27
2025-03-31	$627,349	24,401	-18.8%	Shares	Sole	2026-03-17
2024-12-31	$867,745	30,057	+82.6%	Shares	Sole	2026-03-19
2024-09-30	$390,831	16,463	+273.1%	Shares	Sole	2026-03-31
2024-06-30	$76,283	4,412	-32.8%	Shares	Sole	2026-03-23
2024-03-31	$146,551	6,563	—	Shares	Sole	2026-03-24
2023-12-31 GRPH	—	82,451	+142.2%	Shares	Sole	2026-03-24
2023-09-30 GRPH	—	34,037	+504.0%	Shares	Sole	2026-03-26
2023-06-30 GRPH	—	5,635	-75.8%	Shares	Sole	2026-03-27
2023-03-31 GRPH	—	23,310	+165.5%	Shares	Sole	2026-03-30
2022-03-31 GRPH	—	8,779	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.